 Stephen F. Badylak, MD, PhD |
| | - Regenerative medicine and biologic scaffolds.
|
| Michael J. Becich, MD, PhD |
| | - Cancer biology and bioinformatics.
|
| Dorothea Becker, Ph.D. |
| | - Genes that regulate the onset and progression of melanoma
|
| James Becker, Ph.D. |
| | - human memory disorders, the neuroanatomical damage which produces human memory disorders.
|
| Timothy R. Billiar, MD |
| | - Roles of nitric oxide in acute inflammatory reactions.
|
| Harry C. Blair, MD |
| | - Bone physiology and pathology
|
| Carol Bostwick, PhD |
| | - Mediators of fibrosis in scleroderma skin and lung.
|
| Robert Bowser, PhD |
| | - The molecular and cellular basis of neurodegeneration in human diseases.
|
| Richard Chaillet, MD, PhD |
| | - Molecular mechanisms of epigenetic inheritance and genomic imprinting in mammals
|
| Yuan Chang, MD |
| | - Epidemiology and biological properties of Kaposi's sarcoma-associated herpesvirus.
|
| Shi-Yuan Cheng, PhD |
| | - Molecular Mechanisms of Tumor Angiogenesis.
|
| Charleen T. Chu, MD, PhD |
| | - Cellular and molecular mechanisms of neurodegeneration and neuroprotection in Parkinson's disease and retinal degeneration.
|
| Paula Clemens, MD |
| | - Gene delivery to striated muscle
|
| Marie C. DeFrances, MD, PhD |
| | - PI3K signaling mechanisms in hepatocytes.
|
| Russell L. Delude, PhD |
| | - The molecular mechanism through which NO. regulates epithelial paracellular permeability in normal and disease states.
|
| Anthony J. Demetris, MD |
| | - The role of inflammatory cytokines and growth factors in the development of cirrhosis & tolerance induction and chronic tissue rejection.
|
| H. Henry Dong, PhD |
| | - Insulin Resistance and Diabetic Dyslipidemia.
|
| Albert D. Donnenberg, PhD |
| | - Immunologic consequences of autologous transplantation in
systemic sclerosis, stem and progenitor cells for regenerative therapy.
|
| Anette Duensing, MD |
| | - Molecular biology of gastrointestinal stromal tumors (GISTs) and mechanism of action of targeted therapies.
|
| Ira J. Fox, MD |
| | - Experimental therapies for liver disease and differentiation of human ES and iPS cells into hepatocytes
|
| Chandrashekhar R. Gandhi, Ph.D. |
| | - Mechanisms of liver growth and disease.
|
| Nick Giannoukakis, PhD |
| | - Gene and cell therapy for autoimmunity.
|
| James Gnarra, PhD |
| | - The effects of von Hippel-Lindau (VHL) inactivation and hypoxia on post-transcriptional regulation of vascular endothelial growth factor (VEGF) mRNA..
|
| Jennifer R. Grandis, M.D. |
| | - TGF- /EGFR autocrine signaling in head and neck carcinogenesis
|
| David Hackam, M.D., Ph.D. |
| | - To understand the mechanisms governing the migration of intestinal epithelial cells during conditions of intestinal inflammation
|
| Patricia A. Hebda, PhD |
| | - Wound healing, tissue engineering and pathogenesis of inflammation in otitis media
|
| Johnny Huard, PhD |
| | - Tissue engineering
|
| Naftali Kaminski, MD |
| | - The basic mechanisms underlying pulmonary fibrosis and the way that molecular networks determine tissue and cellular phenotype
|
| Sikandar L. Katyal, PhD |
| | - Pulmonary biology, with emphasis on lung development in utero and regeneration after injury.
|
| Uddhav P. Kelavkar, PhD. |
| | - high-fat diet and the risk for prostate cancer
|
| William Klunk, MD, PhD |
| | - Imaging and treatment in Alzheimer's disease
|
| Scott Kulich, MD, PhD |
| | - the interaction between oxidative neurotoxins and intracellular signal transduction
|
| Eric Lagasse, PhD |
| | - Human stem/progenitor cells for liver diseases.
|
| Jean J. Latimer, PhD |
| | - Human breast tissue engineering and breast cancer research.
|
| Luyuan Li, PhD |
| | - Molecular mechanism of angiogenesis.
|
| Yong Li, PhD |
| | - Adult stem cells and fibrosis in skeletal muscular system
|
| Youhua Liu, PhD |
| | - Experimental Pathologyof renal fibrosis.
|
| Anna E Lokshin, PhD |
| | - Identification of cancer biomarkers for screening, diagnosis, prognosis, and disease monitoring of solid tumo.
|
| Jianhua Luo, MD, PhD |
| | - Analysis of gene expression in human malignancies.
|
| James Lyons-Weiler, PhD |
| | - Optimization of disease prediction modeling in cancer and other diseases
|
| Wendy M. Mars, PhD |
| | - The role of hepatocyte growth factor (HGF) and the plasminogen activator system in tissue regeneration
|
| George Michalopoulos, MD, PhD |
| | - Use the differentiated cells of the liver (hepatocytes) as models to understand the mechanisms that regulate growth of complex differentiated cells and whole organs.
|
| Satdarshan P. Singh Monga, M. D. |
| | - Molecular mechanisms of liver growth and development, in health and disease.
|
| Yuri E. Nikiforov, M.D., Ph.D. |
| | - Molecular mechanisms of radiation-induced carcinogenesis and chromosomal rearrangements in human cells and molecular basis of thyroid cancer.
|
| Erin Ochoa, MD |
| | - Liver senescence, regeneration and proliferation.
|
| Denise S. O'Keefe, PhD |
| | - Epigenetic changes and the etiology of prostate cancer.
|
| Zoltan Oltvai, MD, PhD |
| | - Systems biology
|
| Tim D. Oury, MD, PhD |
| | - Oxidative mechanisms in pulmonary, vascular, and neuro, pathophysiology
|
| Beth R. Pflug, Ph.D. |
| | - Growth regulation and novel therapeutic and imaging targets for prostate cancer.
|
| Jon D. Piganelli, PhD |
| | - T cell mediated effector mechanisms of beta cell destruction in Type I Diabetes (TID).
|
| Lisa J. Robinson, MD |
| | - Signaling mechanisms in the regulation of normal and abnormal myelopoiesis.
|
| William Saunders, Ph.D. |
| | - Cell division and the origin of divisional defects in cancer cells.
|
| Steven D. Shapiro, M.D. |
| | - The biological and pathological function of proteinases in lung
|
| Donna B. Stolz, Ph.D. |
| | - Angiogenesis and endothelial cells proliferate, migrate and differentiation
|
| Stephen C. Strom, PhD |
| | - Liver disease, liver function, and the treatment of defects in liver function by the transplantation of isolated hepatocytes (liver cells).
|
| Urvashi Surti, PhD |
| | - The molecular cytogenetics of pregnancy loss and cancer.
|
| Yoram Vodovotz, PhD |
| | - The biology of shock states, the role and biology of nitric oxide in shock and other inflammatory states
|
| David Vorp, PhD |
| | - Vascular remodeling and regeneration
|
| Zhou Wang, PhD |
| | - The mechanism of androgen action and the roles of androgens in benign and cancerous prostate growth.
|
| Alan Wells, MD, DMS |
| | - The role of cell migration in physiologic and pathologic conditions.
|
| Sally Wenzel, MD |
| | - The pathogenesis of human asthma.
|
| Clayton A. Wiley, MD, PhD |
| | - Pathogenesis of neurodegenerative diseases and in particular on viral induced nervous system diseases.
|
| Cary Wu, PhD |
| | - Cell adhesion: molecular mechanism and the roles in the pathogenesis of cancer and diabetic nephropathy.
|
| Xiao-Ming Yin, MD, PhD |
| | - The molecular mechanisms of apoptosis
|
| Jian Yu, PhD |
| | - The molecular mechanisms of apoptosis in mammalian cells and its role in cancer therapy and carcinogenesis.
|
| Reza Zarnegar, PhD |
| | - The analysis of hepatocyte growth factor (HGF) and HGF receptor (a protooncogene) function and their genetic regulation at the molecular level in vivo.
|
